Search

everythinglearnresearchcommunity

for

Search:↓

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Using drugs to activate the Wnt/β-catenin pathway has potential for treating diseases but also presents challenges.

5α-reductase inhibitors like finasteride and dutasteride can help treat skin disorders stimulated by androgens, such as hair loss and acne.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

PCOS affects many women, causing various symptoms and health risks, and is managed through lifestyle changes, medication, and support groups.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Transethosomes improve drug delivery through the skin and show promise for treating various conditions.

Stopping certain drugs can improve skin conditions, arsenicosis affects over half of a Bangladeshi village, males are more vulnerable, and certain treatments are effective for warts, acne, and psoriasis. Smoking and drinking are linked to psoriasis in men, a cream helps with a type of skin cancer, and low iron levels don't directly cause chronic hair loss in women.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Nanocarriers can improve the effectiveness of herbal medicines in treating colorectal cancer.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.